Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit-Reference-Cited by-同舟云学术

Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit

Published:2016-04-15 Issue:11 Volume:33 Page:1575-1581
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Baxter M.¹,Hudson R.¹,Mahon J.²,Bartlett C.²,Samyshkin Y.³,Alexiou D.³,Hex N.²

Affiliation:

1. Sanofi; Guildford UK

2. York Health Economics Consortium Ltd; University of York; York UK

3. IMS Health; London UK

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.13062/fullpdf

Reference18 articles.

1. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs;Hex;Diabet Med,2012

2. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study;Huang;Diabetes Care,2011

3. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68);Clarke;Diabetologia,2004

4. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS82;Hayes;Diabetologia,2013

5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33;UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge;Value in Health;2024-07

2. Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review;Diabetes Therapy;2024-06-27

3. Estimation of the direct health and indirect societal costs of diabetes in the UK using a cost of illness model;Diabetic Medicine;2024-06-18

4. Progression from Prediabetes to Diabetes in a Diverse U.S. Population: A Machine Learning Model;Diabetes Technology & Therapeutics;2024-04-24

5. pH-responsive mesoporous silica nanorod for high load and oral delivery of insulin;Journal of Drug Delivery Science and Technology;2024-01